The COVID-19 market dislocation could be compared, not only to the Great Recession, but also—inversely—to the “irrational exuberance” of the dot-com era.
As midstream companies consider the impact of the pandemic, their concerns range from immediate questions of intangible asset impairment to longer-term questions about structural impacts on the market.
“Finance executives are devoting more time and resources to determining whether they need to perform an impairment test and, if necessary, record a charge for goodwill.”
The unprecedented disruption businesses face from the impact of COVID-19 on their operations and finances, as well as on the overall economy, have created complex and intricate challenges in goodwill impairment testing processes.
The impact of the proliferation of coronavirus cases on financial markets is creating challenges for companies attempting to wrap up quarterly reporting.
In light of the current market downturn, can we anticipate the impact on control premiums? VRC analyzed the data.
Some of the most significant financial consequences of the novel coronavirus will be seen in both current and coming company disclosures.
PJ Patel will connect with SEC Professionals members and share his insights on the impact of the Coronavirus.
Goodwill Impairment Testing: Is the novel Coronavirus a triggering event and should it be addressed for Q1 or Q2 2020?
Webcast Segment: Is the Coronavirus a triggering event requiring goodwill impairment testing for Q1 or Q2 2020?